Beverly Hills, CA, United States of America

Daniel Berman

This inventor holds 1 USPTO granted patent. Top assignee: Centocor, Inc.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Berman. Retrieved from https://idiyas.com/inventor/daniel-berman-npkfe0h5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel Berman

Introduction

Daniel Berman is a notable inventor based in Beverly Hills, CA. He has made significant contributions to the field of medical imaging, particularly in the area of coronary thrombi. His innovative approach has the potential to enhance diagnostic capabilities in cardiology.

Latest Patents

Berman holds a patent for a method of imaging coronary thrombi. This method involves the administration of a radiolabeled, thrombus-specific antibody or antibody fragment into a coronary artery. The label is then detected to obtain a visual image of the thrombus, providing a crucial tool for medical professionals.

Career Highlights

Daniel Berman is associated with Centocor, Inc., a company known for its advancements in biotechnology and pharmaceuticals. His work at Centocor has allowed him to focus on developing innovative solutions that address critical health issues.

Collaborations

Berman has collaborated with esteemed colleagues such as Jamshid Maddahi and Harvey J. Berger. These partnerships have fostered an environment of innovation and have contributed to the advancement of medical imaging technologies.

Conclusion

Daniel Berman's contributions to the field of medical imaging, particularly through his patented method for imaging coronary thrombi, highlight his role as an influential inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…